Sims EK, Geyer SM, Long SA, Herold KC, et al. High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment. Diabetologia 2023 Sep 4. doi: 10.1007/s00125-023-06003.
PMID: 37667106